Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
ImMAGE Biotherapeutics recently announced that their immunotherapy approach to treat triple negative breast cancer (TNBC) has shown promising results in in vitro studies and is now being tested on ... Read more
Pin It on Pinterest